e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Quality of diagnosis and assessment in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study
T. Harries, P. Seed, S. Jones, P. Schofield, P. White (London, Guildford, United Kingdom)
Source:
Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Session:
Quality of diagnosis and assessment in primary care
Session type:
Poster Discussion
Number:
274
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Harries, P. Seed, S. Jones, P. Schofield, P. White (London, Guildford, United Kingdom). COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study. Eur Respir J 2013; 42: Suppl. 57, 274
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Related content which might interest you:
Cost and effectiveness of integrated care intervention on the patients with COPD
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Investigation for asthma-related healthcare utilization and prescription of pregnant women with asthma in Korea
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
COPD admissions in London: What general practice characteristics are associated?
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Health care workers’ knowledge about COPD and health locus of control
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
LATE-BREAKING ABSTRACT: Impact of the provision of free medications on hospital admissions for asthma in Brazil
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
Inappropriate prescriptions following initial COPD diagnosis
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Predictive value of annual costs on 3-year mortality in COPD
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Asthma prescribing practices, ethnicity and risk of hospital admission: An analysis of linked primary and secondary care records in East London
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Health care utilization and costs of asthma and COPD in the Netherlands
Source: Eur Respir J 2005; 26: Suppl. 49, 383s
Year: 2005
Current and future costs of COPD in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013
Hospital resource use for COPD patients varies by both clinical commissioning group and primary care practices across nine CCGs in the United Kingdom
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Advice given to patients regarding electronic cigarettes by health care professionals
Source: Annual Congress 2013 –E-cigarettes, shisha, the tobacco industry and public health
Year: 2013
Reduction in the use of health care resources in patients enrolled in a public program for management of COPD in Bahia, Northeastern Brazil
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
The relationship between social deprivation and hospital admissions with asthma
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
COPD readmissions in an urban environment: Health service factors
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
Estimating severe asthma prevalence in austria using nationwide prescription data
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Does having specialist asthma nurses improve adherence to national asthma guidelines? A comparison between two UK district general hospitals
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Global asthma network survey of national asthma strategies – Where are the gaps?
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Title: The effect of COPD pay-for-performance program on healthcare resource utilization in Taiwan
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept